Abstract

Bone fractures have a high degree of severity. This is usually a result of the physical trauma of diseases that affect bone tissues, such as osteoporosis. Due to its highly vascular nature, the bone is in a constant state of remodeling. Although those of younger ages possess bones with high regenerative potential, the impact of a disrupted vasculature can severely affect the recovery process and cause osteonecrosis. This is commonly seen in the neck of femur, scaphoid, and talus bone. In recent years, mesenchymal stem cell (MSC) therapy has been used to aid in the regeneration of afflicted bone. However, the cut-off in blood supply due to bone fractures can lead to hypoxia-induced changes in engrafted MSCs. Researchers have designed several oxygen-generating biomaterials and yielded varying degrees of success in enhancing tissue salvage and preserving cellular metabolism under ischemia. These can be utilized to further improve stem cell therapy for bone repair. In this review, we touch on the pathophysiology of these bone fractures and review the application of oxygen-generating biomaterials to further enhance MSC-mediated repair of fractures in the three aforementioned parts of the bone.

Highlights

  • United States Arnaud Scherberich, University Hospital of Basel, Switzerland Xinchen Wu, University of Massachusetts Lowell, United States

  • The cut-off in blood supply due to bone fractures can lead to hypoxia-induced changes in engrafted mesenchymal stem cell (MSC)

  • This review is mainly focused on the use of oxygen releasing biomaterials with mesenchymal stem cell therapy to address hypoxia in the treatment of bone fractures (Figure 1)

Read more

Summary

Frontiers in Cell and Developmental Biology

Due to its highly vascular nature, the bone is in a constant state of remodeling Those of younger ages possess bones with high regenerative potential, the impact of a disrupted vasculature can severely affect the recovery process and cause osteonecrosis. The cut-off in blood supply due to bone fractures can lead to hypoxia-induced changes in engrafted MSCs. Researchers have designed several oxygen-generating biomaterials and yielded varying degrees of success in enhancing tissue salvage and preserving cellular metabolism under ischemia. Researchers have designed several oxygen-generating biomaterials and yielded varying degrees of success in enhancing tissue salvage and preserving cellular metabolism under ischemia These can be utilized to further improve stem cell therapy for bone repair.

BONE ISCHEMIA
Bone and Oxygen Releasing Biomaterials
HYPOXIA LIMITS ORTHOPEDIC TREATMENT EFFICIENCY
OXYGEN RELEASING BIOMATERIALS
Findings
CONCLUSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.